Final Thoughts on Case Study and Treating Multiple Myeloma

Dr Mikhael and expert panel shares his perspective on the impact of management and monitoring strategies used to minimize the risk of adverse events in patients treated with teclistamab and other bispecifics.

Related Videos
View All
Related Content